Coronary Artery Disease Global Market Research Report 2023
October 24, 2023 04:43 ET
|
Research and Markets
Dublin, Oct. 24, 2023 (GLOBE NEWSWIRE) -- The "Coronary Artery Disease Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering.The global coronary artery disease...
Global Coronary Artery Disease (CAD) Market Analysis/Forecast Report 2023-2028 Featuring AstraZeneca, Novartis, Pfizer, Bristol-Myers Squibb, Merck & Co, Viatris, Sanofi, & Amgen
May 15, 2023 07:53 ET
|
Research and Markets
Dublin, May 15, 2023 (GLOBE NEWSWIRE) -- The "Coronary Artery Disease (CAD) Market, Size, Global Forecast 2023-2028, Industry Trends, Growth, Share, Outlook, Impact of Inflation, Opportunity Company...
Worldwide Precision Cardiology Industry to 2027 - by Offering, Sample Type, Technology, Application, End-user and Region
October 26, 2022 07:48 ET
|
Research and Markets
Dublin, Oct. 26, 2022 (GLOBE NEWSWIRE) -- The "Global Precision Cardiology Market: Competition Forecast and Opportunities to 2027" report has been added to ResearchAndMarkets.com's offering.The...
Outlook on the Global Refractory Angina Industry to 2030 - 11-Year Forecast of Refractory Angina Epidemiology
September 09, 2020 06:53 ET
|
Research and Markets
Dublin, Sept. 09, 2020 (GLOBE NEWSWIRE) -- The "Refractory Angina (RA) - Epidemiology Forecast to 2030" report has been added to ResearchAndMarkets.com's offering. This report delivers an in-depth...
Avinger Announces Successful Treatment of 500th Patient with Next-Generation Pantheris Device
December 13, 2018 07:00 ET
|
Avinger, Inc.
REDWOOD CITY, Calif., Dec. 13, 2018 (GLOBE NEWSWIRE) -- Avinger, Inc. (Nasdaq: AVGR), a leading developer of innovative treatments for peripheral artery disease (PAD), today announced that...
Avinger to Announce First Quarter 2018 Financial Results on May 14, 2018
May 04, 2018 08:00 ET
|
Avinger, Inc.
REDWOOD CITY, Calif., May 04, 2018 (GLOBE NEWSWIRE) -- Avinger, Inc. (Nasdaq:AVGR), a leading developer of innovative treatments for peripheral artery disease (PAD), today announced that it will...
Avinger’s Next Generation Pantheris Featured in Live Case Transmission at Charing Cross International Symposium 2018
April 30, 2018 08:30 ET
|
Avinger, Inc.
REDWOOD CITY, Calif., April 30, 2018 (GLOBE NEWSWIRE) -- Avinger, Inc. (NASDAQ:AVGR), a leading developer of innovative treatments for peripheral artery disease (PAD), announced that its next...
Avinger Announces First-in-Patient use of Extended Nosecone Version of Next Generation Pantheris
March 29, 2018 09:00 ET
|
Avinger, Inc.
REDWOOD CITY, Calif., March 29, 2018 (GLOBE NEWSWIRE) -- Avinger, Inc. (Nasdaq:AVGR), a leading developer of innovative treatments for peripheral artery disease (PAD), today announced that Arne...